Tritium labelling and characterization of the cognition enhancing drug tacrine using several precursors

Applied Radiation and Isotopes

Volumn 57, Issue 6, 2002, Pages 837-840

  Egan, Judith A ^a   Nugent, Richard P ^a   Filer, Crist N ^a  

^a PERKINELMER INC   (United States)

Author keywords

Tacrine; Tritium; Tritium NMR

Indexed keywords

CATALYSIS; CHEMOTHERAPY; DEHALOGENATION; DISEASES;

RADIOLIGAND;

TRITIUM;

A 3773; ANTIINFECTIVE AGENT; BROMINE; RADIOLIGAND; TACRINE; TRITIUM;

ALZHEIMER DISEASE; ARTICLE; BINDING ASSAY; CATALYSIS; CHEMOTHERAPY; COGNITION; DEHALOGENATION; DRUG ACTIVITY; DRUG MECHANISM; DRUG RECEPTOR BINDING; PRIORITY JOURNAL;

CHOLINESTERASE INHIBITORS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; MAGNETIC RESONANCE SPECTROSCOPY; NOOTROPIC AGENTS; SPECTROPHOTOMETRY, ULTRAVIOLET; TACRINE; TRITIUM;

EID: 0036888487     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8043(02)00168-9     Document Type: Article

References (8)

1. Bartus R.T., Dean R.L., Beer B., Lippa A.S. The cholinergic hypothesis of geriatric memory dysfunction. Science. 217:1982;408-417.
2. Boyd W.D., Graham-White J., Blackwood G., Glen I., McQueen J. Clinical effects of choline in Alzheimer senile dementia. Lancet. 2:1977;711.
3. Davies P., Maloney A.J.F. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet. 2:1976;1403.
4. 3H]THA (tetrahydroaminoacridine) binding sites in rat brain. Pharm. Res. 8:1991;200-203.
5. Moghul S., Wilkinson D. Use of acetylcholinesterase inhibitors in Alzheimer's disease. Expert Rev. Neurotherapeutics. 1:2001;61-69.
6. Mohs R.C., Davis B.M., Johns C.A., Mathe A.A., Greenwald B.S., Horvath T.B., Davis K.L. Oral physostigmine treatment of patients with Alzheimer's disease. Am. J. Psychiatry. 142:1985;28-33.
7. Nielsen J.A., Mena E.E., Williams I.H., Nocerini M.R., Liston D. Correlation of brain levels of 9-amino-1,2,3,4-tetrahydroacridine (THA) with neurochemical and behavioral changes. Eur. J. Pharmacol. 173:1989;53-64.
8. Summers W.K., Majovski L.V., Marsh G.M., Tachiki K., Kling A. Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. N. Engl. J. Med. 315:1986;1241-1245.